#United States #San Francisco #AI Platform #Women's Health #Xella Health

The Launch of Xella Health: A New Era in Women's Health Diagnostics

In a groundbreaking move for women's health, Xella Health has officially launched as the first AI-driven platform specifically designed to address the unique diagnostic needs of women. With a staggering 15,000-woman waitlist, the company aims to bridge the gender diagnostic and care gap that has persisted in healthcare for far too long.

Historically, women's health issues have been greatly underfunded compared to those of men, despite women making up half the population and significantly influencing healthcare decisions. Xella Health utilizes proprietary AI technology that processes billions of data points from clinical inputs and multi-omic biomarkers, allowing it to detect over 130 conditions unique to female biology. These include conditions like polyendocrine metabolic ovarian syndrome (PMOS, formerly recognized as PCOS), perimenopause, and endometriosis.

Founders and Vision

Founded by Kelly Lacob, Adriana Dantas, and Dr. Jesus Ching, PhD, Xella Health comes from a rich background in molecular diagnostics and personal experiences that highlight the long road many women endure before being accurately diagnosed. Every year, countless women suffer from debilitating symptoms, such as severe period pain and chronic fatigue, yet these issues are often dismissed by healthcare providers.

“As a group, women have been trapped in what we call a 'diagnostic dark age'. Too often, our debilitating symptoms are overlooked, leading to unfortunate delays in diagnosis—averaging four years longer than men. It’s time to replace systemic medical gaslighting with actionable data,” claims Kelly Lacob, Co-Founder and CEO of Xella Health.

How Xella Works

1. Clinical Testing

At enrollment, members of Xella Health complete a detailed onboarding questionnaire and schedule a blood draw at local partner labs like Quest or Labcorp. Home visits by phlebotomists are also available, providing a convenient option for members.

2. AI-Driven Probability Risk Profiling

Xella's cutting-edge AI technology analyzes biomarker data from various sources, including genomics, hormones, and medical histories, to identify female-specific conditions. The breadth of this analysis includes PMOS (PCOS), Hashimoto's disease, premensural dysphoric disorder (PMDD), and timelines for menopause transition, effectively creating individualized health profiles for each member.

3. Integrated Care via Telehealth

Following testing, results are processed in Xella's CLIA-certified lab, leading to personalized healthcare roadmaps. Members are paired with certified telehealth physicians who help interpret findings and establish actionable clinical plans. These plans may include hormone therapy or referrals to specialists, thus providing a streamlined path toward effective treatment.

Adriana Dantas, Co-Founder, mentions, “Historically, women’s health data has been segregated; symptoms were assessed in isolation rather than looking at the holistic picture. By connecting these biological patterns over time, we provide not just data but also a clear pathway to health.”

A Team of Experts and Backing

Xella Health is supported by pioneers in precision health, including Dr. Allison Kurian, MD, PhD, from Stanford University and Dr. Lynn Westphal, MD, an expert in reproductive endocrinology. The company has secured $4.7 million in funding from early-stage investors such as Precursor Ventures and Ulu Ventures, indicating strong belief in its innovative approach to women's health.

The emphasis on women's health is gaining momentum, fueled by a $15 trillion female economy. Xella Health exemplifies the potential for deep clinical expertise to meet consumer needs in this burgeoning sector. As investors and consumers alike increasingly recognize the demand for specialized women's healthcare solutions, Xella is well-positioned for rapid growth.

Membership and Accessibility

Membership for Xella Health is priced at $499 annually, which is eligible for Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA). This membership grants access to all precision health platform features, including testing, personalized clinical reports, and ongoing consultations with a dedicated clinical team. As services expand, additional screenings will also be available, providing enhanced insights into fertility and perimenopause.

As of now, Xella is operational across 48 states, with plans to introduce services to New York and New Jersey by early 2027.

Conclusion

With Xella Health, women can finally attain clarity regarding their health rather than relying on disjointed medical perspectives. By utilizing advanced AI technology and focusing on the specific needs of female patients, Xella Health is poised to transform women's healthcare as we know it, offering empowering solutions that acknowledge and address the unique challenges faced by women today.

For more information or to join the waitlist, visit joinxella.com.